In partnership with the United Nations Office on Drugs and Crime (UNODC) and led by the Vienna Non Governmental Organisations Committee on Narcotic Drugs (VNGOC) 300 NGO delegates, from all regions of the world, met to debate and construct a consensus on policy recommendations and on mechanisms for NGOs and the government to work together.
The priorities of the French Presidency of the EU have been published and the fight against drugs and drug addiction has been expressly included as a constant objective essential to the protection of citizens. The French presidency will facilitate the negotiation of the new EU action plan against drugs for 2009 - 2012 and prepare EU positions and strategy for the CND.
Paola Barahona, MPH, a Global Health Policy Associate with Physicians for Human Rights, Washington, is reaching out to friends, family, and colleagues and asking them to consider signing the attached petition to the Government of Iran on behalf of Drs. Kamiar Alaei and Arash Alaei, physician brothers who have been working on HIV and drug use in Iran for many years.
Alcohol, tobacco, and illegal drug use cause considerable morbidity and mortality, but good cross-national epidemiological data are limited. This paper describes such data from the first 17 countries participating in the World Health Organization's (WHO's) World Mental Health (WMH) Survey Initiative.
Following the call at the AIDS High Level Meeting in New York for more effective HIV prevention amongst injecting drug users, a group of NGOs initiated a sign on letter to senior UN officials pointing out the contradictions between the drive to tackle this problem, and the stigmatisation and marginalisation of drug users that is often part of UN-supported drug control activities.
On June 19, 2008, WOLA Senior Associate John_Walsh testified before Joint Economic Committee of the US Congress (chaired by Senator Jim Webb, Democrat of Virginia) on U.S. drug policy.
To provide our network and partners with concise information on the background to the UNGASS 10-year review, the IDPC has produced an Advocacy Guide that explains the structures, processes and issues involved.
As the process of reviewing the 10-year achievements of the global drug control system continues, the IDPC has been synthesising the wide range of publications and analysis from its members into brief advocacy notes that summarise our positions on the key issues in this review.